Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline
摘要:
With the aim to investigate the effect of different heterocyclic rings linked to the 4-aminoquinoline nucleus on the antimalarial activity, a set of 7-chloro-N-(heteroaryl)-methyl-4-aminoquinoline and 7-chloro-N-(heteroaryl)-4-aminoquinoline was synthesized and tested in vitro against D-10 (CQ-S) and W-2 (CQ-R) strains of Plasmodium falciparum. All compounds exhibited from moderate to high antiplasmodial activities. The activity was strongly influenced both by the presence of a methylenic group, as a spacer between the 4-aminoquinoline and the heterocyclic ring, and by the presence of a basic head. The most potent molecules inhibited the growth of both CQ-S and CQ-R strains of P. falciparum with IC50 < 30 nM and were not toxic against human endothelial cells. These results confirm that the presence of an heteroaryl moiety in the side chain of 7-chloro-4-aminoquinoline is useful for the design and development of new powerful antimalarial agents. (C) 2012 Elsevier Ltd. All rights reserved.
Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline
摘要:
With the aim to investigate the effect of different heterocyclic rings linked to the 4-aminoquinoline nucleus on the antimalarial activity, a set of 7-chloro-N-(heteroaryl)-methyl-4-aminoquinoline and 7-chloro-N-(heteroaryl)-4-aminoquinoline was synthesized and tested in vitro against D-10 (CQ-S) and W-2 (CQ-R) strains of Plasmodium falciparum. All compounds exhibited from moderate to high antiplasmodial activities. The activity was strongly influenced both by the presence of a methylenic group, as a spacer between the 4-aminoquinoline and the heterocyclic ring, and by the presence of a basic head. The most potent molecules inhibited the growth of both CQ-S and CQ-R strains of P. falciparum with IC50 < 30 nM and were not toxic against human endothelial cells. These results confirm that the presence of an heteroaryl moiety in the side chain of 7-chloro-4-aminoquinoline is useful for the design and development of new powerful antimalarial agents. (C) 2012 Elsevier Ltd. All rights reserved.
Design and synthesis of chiral 2 H -chromene- N -imidazolo-amino acid conjugates as aldose reductase inhibitors
作者:Gudipudi Gopinath、Venu Sankeshi、Shaym perugu、Malini D. Alaparthi、Srinivas Bandaru、Vijay K. Pasala、Prasad Rao Chittineni、G.L.David Krupadanam、Someswar R. Sagurthi
DOI:10.1016/j.ejmech.2016.08.070
日期:2016.11
Aldosereductase (ALR2) inhibitors provide a viable mode to fight against diabetic complications. ALR2 exhibit plasticity in the active site vicinities and possible shifts in the nearby two supporting alpha helices. Therefore, a novel series of amino acid conjugates of chromene-3-imidazoles (13–15) were designed and synthesized based on natural isoflavonoids. The compounds were identified on the basis
醛糖还原酶(ALR2)抑制剂为对抗糖尿病并发症提供了一种可行的模式。ALR2在活动部位附近表现出可塑性,并且在附近的两个支撑α螺旋中可能发生位移。因此,在天然异黄酮的基础上,设计并合成了一系列新的色烯-3-咪唑(13-15)的氨基酸缀合物。根据光谱数据(1 H NMR,13 C NMR和MS)鉴定化合物,并在体外测试ALR2抑制活性,IC 50值范围为0.031± 0.082μM至4.29±0.55μM。我们的计算机和生化研究证实了15e在对醛还原酶(ALR1)具有高选择指数的合成化合物中,具有最佳的抑制活性。向STZ诱导的大鼠补充15e可以降低血糖水平,并以剂量依赖性方式延缓白内障的进展。因此,本研究提供了具有希望的抑制剂以预防或延缓白内障进展的一系列新化合物。
Role of benzimidazole (Bid) in the δ-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH2-Bid (UFP-502)☆
作者:Severo Salvadori、Stella Fiorini、Claudio Trapella、Frank Porreca、Peg Davis、Yusuke Sasaki、Akihiro Ambo、Ewa D. Marczak、Lawrence H. Lazarus、Gianfranco Balboni
DOI:10.1016/j.bmc.2007.12.032
日期:2008.3.15
H-Dmt-Tic-NH-CH2-Bid (UFP-502) was the first delta-opioid agonist prepared from the Dmt-Tic pharmacophore. It showed interesting pharmacological properties, such as stimulation of mRNA BDNF expression and antidepression. To evaluate the importance of 1H-benzimidazol-2-yl (Bid) in the induction of delta-agonism, it was substituted by similar heterocycles: The substitution of NH(1) by O or S transforms the reference delta-agonist into delta-antagonists. Phenyl ring of benzimidazole is not important for delta-agonism; in fact 1H-imidazole-2-yl retains delta-agonist activity. (C) 2007 Elsevier Ltd. All rights reserved.